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The neuronal adaptor protein X11α/mint-1/APBA-1 binds to the cytoplasmic domain of the amyloid precursor protein (APP) to modulate its trafficking and metabolism. We investigated the consequences of reducing X11α in a mouse model of Alzheimer's disease (AD). We crossed hAPPswe/PS-1ΔE9 transgenic (AD tg) mice with X11α heterozygous knockout mice in which X11α expression is reduced by approximately 50%. The APP C-terminal fragments C99 and C83, as well as soluble Aβ40 and Aβ42, were increased significantly in brain of X11α haploinsufficient mice. Aβ/amyloid plaque burden also increased significantly in the hippocampus and cortex of one year old AD tg/X11α (+/−) mice compared to AD tg mice. In contrast, the levels of sAPPα and sAPPβ were not altered significantly in AD tg/X11α (+/−) mice. The increased neuropathological indices of AD in mice expressing reduced X11α suggest a normal suppressor role for X11α on CNS Aβ/amyloid deposition. © 2009 Elsevier Inc. All rights reserved.
The progressive accumulation and deposition of Aβ/amyloid play a central role in Alzheimer's disease (AD) pathogenesis (Selkoe and Schenk, 2003) . Accordingly, the metabolism and processing of the amyloid precursor protein (APP) are critically important in AD (reviewed in Turner, 2006) . Cytoplasmic adaptor proteins, including those in the X11 and Fe65 families, regulate APP catabolism in vitro and in vivo (King and Turner, 2004; Miller et al., 2006) . The X11 family constitutes multidomain adaptor proteins composed of a PTB domain and two C-terminal PDZ domains involved in forming multiprotein complexes. For example, the PTB domain of X11α/ mint-1 (munc18-1-interacting protein)/APBA-1 (Amyloid Precursor Binding protein A-1)), binds to the conserved -YENPTY -motif in the cytoplasmic domain of APP to modulate its trafficking and metabolism (Bοrg et al., 1998a; King et al., 2003; Saluja et al., 2007) . Overexpression of X11α or X11β in vitro inhibits APP catabolism, increases the half-life of APP, and reduces the levels of secreted APP (sAPP) and Aβ (Borg et al., 1998b; Sastre et al., 1998; McLoughlin et al., 1999; Mueller et al., 2000; Biederer et al., 2002; Saluja et al., 2007) . Overexpression of X11α or X11β in vivo reduces Aβ/amyloid plaque deposition in AD tg mice (Lee et al., 2003 (Lee et al., , 2004 ). X11α does not inhibit the catabolism of C-terminal fragments of APP in a cellfree in vitro system, suggesting that X11α inhibits Aβ generation from APP by impairing its trafficking to subcellular sites of active γ-secretase complexes (King et al., 2004) .
X11α and X11β are expressed primarily in neurons (Okamoto et al., 2000) , while X11γ is ubiquitously expressed. X11 proteins are implicated in neuronal signaling and plasticity, protein targeting and tethering, and trafficking of protein complexes. They may be involved in both pre-synaptic and post-synaptic functions (King and Turner, 2004) . In pre-synaptic neurons, X11α interacts with munc -a protein essential for neurotransmitter vesicle docking and exocytosis (Okamoto and Südhof, 1997; Ho et al., 2006) . In the postsynaptic region, X11α is a component of protein complexes mediating glutamate receptor trafficking (Rongo et al., 1998; Hong and Hsueh, 2006) .
Recent studies employing knockout mice or RNAi-mediated suppression of X11 family proteins have yielded conflicting results on the role of X11 protein family in APP metabolism and Aβ generation. Studies in X11α and X11β double KO mice showed an increase in endogenous murine APP C-terminal fragments and Aβ (Sano et al., 2006; Saito et al., 2008) . In contrast, RNAi-mediated knockdown in vitro of X11α/mint-1 or X11β/mint-2 was shown to inhibit γ-cleavage of APP-CTFs and reduce Aβ generation (Xie et al., Neurobiology of Disease 36 (2009) [162] [163] [164] [165] [166] [167] [168] 
